Valuation : Novartis AG

Market Cap 295B 254B 238B 217B 410B 28,174B 411B 2,826B 1,102B 14,222B 1,107B 1,083B 47,158B P/E 2026 *
22x
P/E 2027 * 18.8x
Enterprise Value 327B 282B 265B 242B 455B 31,297B 456B 3,139B 1,225B 15,799B 1,229B 1,203B 52,386B EV / Sales 2026 *
5.68x
EV / Sales 2027 * 5.26x
Free-Float
91.66%
Yield 2026 *
2.82%
Yield 2027 * 2.94%
1 day-0.53%
1 week-2.89%
Current month-2.26%
1 month-5.11%
3 months+4.63%
6 months-4.79%
Current year+12.90%
1 week 123.42
Extreme 123.42
128.68
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-2.89%+21.86%+36.79% 295B
-0.60%-6.89%+59.69%+111.02% 1,048B
+0.08%-1.65%+51.48%+61.77% 640B
-0.58%-3.18%+23.38%+74.00% 456B
-1.46%-4.50%+37.43%+38.41% 362B
-1.19%-2.21%+1.35%+10.79% 255B
-1.07%-1.63%+51.31%+68.45% 236B
+0.08%-1.78%-17.64%-54.29% 204B
-2.32%-0.38%+29.32%+88.94% 185B
-0.52%-0.89%+13.09%-23.17% 160B
Average -0.80%-0.63%+27.13%+41.27% 384.13B
Weighted average by Cap. -0.66%-1.83%+37.12%+61.19%

Financials

2026 *2027 *
Net sales 57.65B 49.68B 46.58B 42.52B 80.1B 5,510B 80.35B 553B 216B 2,781B 216B 212B 9,222B 61.31B 52.83B 49.53B 45.22B 85.18B 5,860B 85.45B 588B 229B 2,958B 230B 225B 9,808B
Net income 13.95B 12.02B 11.27B 10.29B 19.38B 1,333B 19.44B 134B 52.18B 673B 52.38B 51.24B 2,232B 15.5B 13.36B 12.52B 11.43B 21.54B 1,482B 21.61B 149B 57.98B 748B 58.2B 56.94B 2,480B
Net Debt 32.68B 28.16B 26.4B 24.1B 45.4B 3,123B 45.55B 313B 122B 1,577B 123B 120B 5,228B 27.82B 23.97B 22.47B 20.52B 38.65B 2,659B 38.77B 267B 104B 1,342B 104B 102B 4,450B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
28/08/26 CHF 123.74 -0.72% 1,961,272
27/08/26 CHF 124.64 -2.00% 1,891,362
26/08/26 CHF 127.18 -0.90% 1,481,053
25/08/26 CHF 128.34 +1.25% 1,729,051
24/08/26 CHF 126.76 -0.52% 1,658,623
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.09USD
Average target price
154.32USD
Spread / Average Target
-0.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock